NATURAL HEALTH TRENDS CORP
NHTCDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
Get an email about NHTC's next catalysts
Track NATURAL HEALTH TRENDS (NHTC) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming, 0 past
NHTC Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Heptex | Phase 2 | Nonalcoholic Steatohepatitis | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in NATURAL HEALTH TRENDS CORP's drug pipeline?→
CatalystAlert tracks 1 drug candidate in NATURAL HEALTH TRENDS CORP's (NHTC) pipeline across Phase 2. Its lead program is Heptex (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is NATURAL HEALTH TRENDS CORP's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for NATURAL HEALTH TRENDS CORP (NHTC) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NHTC biotech catalysts?→
Add NHTC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NATURAL HEALTH TRENDS CORP's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.